| Title: | Phytopharmaceutical Lead for the Management of Osteoarthritis |
| Value Proposition: | It is an enriched fraction of boswellic acids from Boswellia serrata gum resin containing four biomarkers showing significant osteoarthritis pain-relieving effect in monosodium iodoacetate (MIA) induced Osteoarthritis pain model in Sprague Dawley Rats. |
| Summary Application: | For the management of the pain in Osteoartritic condition. |
| Advantages: | Novel phytopharmaceutical formulation for the management of the pain in the osteoarthritis. |
| Tech. Readiness Level: |